Pillstats
Rx only · Inhalant · Oral

Treprostinil

Brands: Tyvaso · Tyvaso Dpi · Treprostinil

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US11 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCB01AC21
RxCUI (US)343048
US makers1 labelers
Packages14
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7011.4K2.1K2.8K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.8K
Rx · 2026 Q1
59K
Units dispensed
-26%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
United Therapeutics Corporationunknown14SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Aug 14, 2018
    RECALLRecall (Class III): Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution. Treprostinil 1.74 mg/2…

    Defective Delivery System: Water ingress through the lower water cup sensor of the device. — Recalling firm: United Therapeutics Corp. — IL, PA